IgA Nephropathy Across the Age Spectrum
- 1 July 2026
- journal article
- Published by Wolters Kluwer Health in Clinical Journal of the American Society of Nephrology
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Immunoglobulin A Nephropathy: New Treatment OptionsAnnual Review of Medicine, 2026
- Kidney injury and colocalization of complement C3, IgA, and IgG in glomerular immune-complex deposits of patients with IgA nephropathy or IgA vasculitis with nephritisKidney International, 2025
- KDIGO 2025 Clinical Practice Guideline for the Management of Immunoglobulin A Nephropathy (IgAN) and Immunoglobulin A Vasculitis (IgAV)Kidney International, 2025
- IPNA clinical practice recommendations for the diagnosis and management of children with IgA nephropathy and IgA vasculitis nephritisPediatric Nephrology, 2024
- Long-Term Outcomes in IgA NephropathyClinical Journal of the American Society of Nephrology, 2023
- Soluble CD89 is a critical factor for mesangial proliferation in childhood IgA nephropathyKidney International, 2022
- Clinical and histological differences between adults and children in new onset IgA nephropathyPediatric Nephrology, 2020
- Intensive Supportive Care plus Immunosuppression in IgA NephropathyNew England Journal of Medicine, 2015
- Mortality Risk Among Children Initially Treated With Dialysis for End-Stage Kidney Disease, 1990-2010JAMA, 2013
- Clinicopathologic correlations of renal pathology in SpainKidney International, 2004